Understanding metabolic pathways for skin anti-aging

Journal of Drugs in Dermatology

Volumn 8, Issue 7, 2009, Pages

  Osborne, Rosemarie ^a   Mullins, Lisa A ^a   Jarrold, Bradley B ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COSMETIC; DIPEPTIDE; HEXAMIDINE; HYALURONIC ACID; LAMININ 1; LAMININ IV; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; MESSENGER RNA; N ACETYLGLUCOSAMINE; NICOTINAMIDE; PAL KT PEPTIDE; PENTAPEPTIDE; POLYMER; PROCOLLAGEN TYPE 1; PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG; DERMATOLOGICAL AGENT;

ARTICLE; BASEMENT MEMBRANE; CUTANEOUS PARAMETERS; GENE EXPRESSION; HYPERPIGMENTATION; IN VITRO STUDY; METABOLISM; MICROARRAY ANALYSIS; SKIN CELL; SKIN CULTURE; SKIN DISCOLORATION; STRATUM CORNEUM; WATER LOSS; WRINKLE; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; HUMAN; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; PERMEABILITY; SKIN; TISSUE ENGINEERING;

ADMINISTRATION, CUTANEOUS; BIOLOGICAL MARKERS; DERMATOLOGIC AGENTS; GENE EXPRESSION PROFILING; HUMANS; PERMEABILITY; SKIN; SKIN AGING; TISSUE ENGINEERING;

EID: 68349103154     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Robinson MK, Binder RL, Griffiths CEM. Genomic-driven insights into changes in aging skin. J Drugs Dermatol. 2009;8(7 Suppl).
2. Weinkle SH, Tiesman J. Genomics of skin aging: practical applications. J Drugs Dermatol. 2009; 8(7 Suppl):s8-s11.
3. Tiesman J. From bench to beauty counter: Using genomics to drive technology development for skin care. J Drugs Dermatol. 2009;8(7 Suppl):s12-s14.
4. Kaczvinsky JR Jr, Grimes PE . Practical applications of genomics research for treatment of aging skin. J Drugs Dermatol. 2009; 8(7 Suppl):S15-S18.
5. McLaughlin CR, Osborne R, Dare EV, et al. Tissue engineered models for in vitro studies. Tissue Eng. 2009; in press.
6. Pinnagoda J, Tupker RA, Agner T, Serup J. Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis. 1990;22(3):64-178.
7. Oestmann E, Lavrijsen AP, Hermans J, Ponec M. Skin barrier function in healthy volunteers as assessed by transepidermal water loss and vascular response to hexyl nicotinate: Intra- and inter-individual variability. Br J Dermatol. 1993;128(2):130-136. (Pubitemid 23054329)
8. Jarrold BB, Mullins LA, Binder RL, Osborne R. Expression profiles of stratum corneum lipid metabolism pathways associated with intrinsic and extrinsic aging. J Am Acad Dermatol. 2009;60(Supp l):AB28.
9. Lintner K, Peschard O. Biologically active peptides: from a laboratory bench curiosity to a functional skin care product. Int J Cosmet Sci. 2000;22(3):207-218. (Pubitemid 30389327)
10. Lintner K. Promoting ECM production without compromising barrier. Ann Dermatol Venereol. 2002;129:1S105.
11. Mullins LA, Jarrold BB, Lintner K, Osborne R. In vitro skin biomarker responses to a new anti-aging peptide, Pal-KT. J Am Acad Dermatol. 2009;60(Supp l):AB82.
12. Weindl G, Schaller M, Schäfer-Korting M, Korting HC. Hyaluronic acid in the treatment and prevention of skin diseases: Molecular biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol. 2004;17(5):207-13. (Pubitemid 39370251)
13. Sayo T, Sakai S, Inoue S. Synergistic effect of N-acetyl glucosamine and retinoids on hyaluronan production in human keratinocytes. Skin Pharmacol Physiol. 2004;17(2):77-83. (Pubitemid 38250514)
14. Ghersetich I, Lotti T, Campanile G, et al. Hyaluronic acid in cutaneous instrinsic aging. Int J Dermatol. 1994;33(2):119-22. (Pubitemid 24141902)